Samba-AC: A Randomized, Open-Label, Cross-Over Study to Investigate the PK and PD Profiles of Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Healthy Subjects and Non-Diabetic Subjects With Mild to Moderate Asthma or COPD
Phase of Trial: Phase I
Latest Information Update: 11 May 2018
At a glance
- Drugs Insulin (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms Samba-AC
- Sponsors Dance Biopharm
- 01 May 2018 Planned End Date changed from 17 Jul 2018 to 30 Aug 2018.
- 01 May 2018 Planned primary completion date changed from 31 May 2018 to 30 Jul 2018.
- 01 May 2018 Status changed from not yet recruiting to recruiting.